ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,104.01
0.08%
US Tech 100
17,298.79
0.34%
Dow Jones
38,305.65
0.17%
Brent Oil
87.175
-0.58%
Bitcoin
62,793.88
-0.33%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. GreenLight Biosciences Holdings PBC (GRNA)

  7. GreenLight Biosciences Holdings PBC (GRNA) News

GreenLight Biosciences Holdings PBC

GreenLight Biosciences Holdings PBC (GRNA)

NASDAQ
0.2995
0.00
( 0.00% )
Updated: 20:00:00
Delayed by 15 minutes

Get an advanced news scanner tailored to your needs by ADVFN

Enhance your trading experience

GRNA News

Official News Only

Form 15-12G - Securities registration termination [Section 12(g)]
Edgar (US Regulatory)
August 11 2023
GRNA (0.00%)

Form 8-K/A - Current report: [Amend]
Edgar (US Regulatory)
July 28 2023
GRNA (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
July 27 2023
GRNA (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
July 27 2023
GRNA (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
July 27 2023
GRNA (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
July 26 2023
GRNA (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
July 26 2023
GRNA (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
July 26 2023
GRNA (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
July 26 2023
GRNA (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
July 26 2023
GRNA (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
July 26 2023
GRNA (0.00%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
July 26 2023
GRNA (0.00%)

GRNA Discussion

View Posts
The Night Stalker The Night Stalker 11 months ago
nice
👍️0
TheFinalCD TheFinalCD 11 months ago
$GRNA NEWS https://finance.yahoo.com/news/greenlight-biosciences-enters-definitive-merger-110100839.html
👍️0
TheFinalCD TheFinalCD 11 months ago
05/30/2023 06:55:09 GRNA GreenLight Biosciences NASDAQ
T1
T2
05/30/2023 06:55:09 GRNAW GreenLight Biosciences Wt NASDAQ
T1
T2
https://www.nasdaqtrader.com/trader.aspx?id=tradehalts
👍️0
BEIJING BILL BEIJING BILL 1 year ago
bouncing off lows of .31
👍️0
TheFinalCD TheFinalCD 1 year ago
$GRNA NEWS https://finance.yahoo.com/news/greenlight-biosciences-epivax-therapeutics-sign-122000914.html
👍️0
makinezmoney makinezmoney 2 years ago
$GRNA: Big pop...... now 6.85

Just cuz



GO $GRNA
👍️0
crudeoil24 crudeoil24 2 years ago
GreenLight Biosciences shares are trading higher after Samsung Biologics and the company announced the completion of the first commercial-scale engineering run for the companies' mRNA production partnership.
👍️0
crudeoil24 crudeoil24 2 years ago
GreenLight Biosciences Holdings, PBC, formerly Environmental Impact Acquisition Corp, is a biotechnology company. The Company is focused on Ribonucleic acid (RNA) research, design, and manufacturing for human, animal, and plant health. The Company has developed technology to create high-performing, natural ribonucleic acid (RNA) products to address global sustainability challenges and promote healthier plants, foods, and people. The Company is engaged in the cell-free biomanufacturing platform. This platform enables the making of complex biological molecules nucleic acids, peptides, carbohydrates, and many others which allows manufacturing products at a lower cost than traditional methods using fermentation. The platform is used to develop and commercialize products. The Company's pipeline for plant and animal health includes Colorado potato beetle, Botrytis cinerea, Varroa mites, Fungicides, Grapevine powdery mildew, Fusarium Head Blight (FHB), Lepidoptera, and Powdery mildew.
👍️0

Your Recent History

NASDAQ
GRNA
GreenLight Biosciences H...
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved